SI2710015T1 - Polimorf rifaximina in postopek za njegovo pripravo - Google Patents

Polimorf rifaximina in postopek za njegovo pripravo

Info

Publication number
SI2710015T1
SI2710015T1 SI201230663A SI201230663A SI2710015T1 SI 2710015 T1 SI2710015 T1 SI 2710015T1 SI 201230663 A SI201230663 A SI 201230663A SI 201230663 A SI201230663 A SI 201230663A SI 2710015 T1 SI2710015 T1 SI 2710015T1
Authority
SI
Slovenia
Prior art keywords
rifaximin
polymorph
preparation
Prior art date
Application number
SI201230663A
Other languages
English (en)
Inventor
Enrico Vigano'
Renato Molteni
Simona Lanfranconi
Massimiliano Arrighi
Fabio Gatti
Original Assignee
Clarochem Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarochem Ireland Limited filed Critical Clarochem Ireland Limited
Publication of SI2710015T1 publication Critical patent/SI2710015T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI201230663A 2011-05-19 2012-05-18 Polimorf rifaximina in postopek za njegovo pripravo SI2710015T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000890A ITMI20110890A1 (it) 2011-05-19 2011-05-19 Polimorfo di rifaximina e processo per la sua preparazione
PCT/IB2012/052506 WO2012156951A1 (en) 2011-05-19 2012-05-18 Polymorph of rifaximin and process for the preparation thereof
EP12731691.7A EP2710015B1 (en) 2011-05-19 2012-05-18 Polymorph of rifaximin and process for the preparation thereof

Publications (1)

Publication Number Publication Date
SI2710015T1 true SI2710015T1 (sl) 2016-09-30

Family

ID=44533008

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201230663A SI2710015T1 (sl) 2011-05-19 2012-05-18 Polimorf rifaximina in postopek za njegovo pripravo

Country Status (15)

Country Link
US (1) US8877770B2 (sl)
EP (1) EP2710015B1 (sl)
KR (2) KR20180032677A (sl)
CN (1) CN103619852B (sl)
AU (1) AU2012257360B2 (sl)
BR (2) BR112013029706A2 (sl)
CA (1) CA2844765C (sl)
ES (1) ES2586124T3 (sl)
IT (1) ITMI20110890A1 (sl)
MX (1) MX348393B (sl)
PL (1) PL2710015T3 (sl)
PT (1) PT2710015T (sl)
RU (1) RU2593750C2 (sl)
SI (1) SI2710015T1 (sl)
WO (1) WO2012156951A1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2522895T3 (es) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
US9018684B2 (en) 2009-11-23 2015-04-28 California Institute Of Technology Chemical sensing and/or measuring devices and methods
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US20140308350A1 (en) 2013-04-12 2014-10-16 Alfa Wassermann S.P.A. Nsaid administration and related compositions, methods and systems
US9788466B2 (en) 2013-04-16 2017-10-10 Skyworks Solutions, Inc. Apparatus and methods related to ground paths implemented with surface mount devices
ITMI20131307A1 (it) 2013-08-02 2015-02-02 A M S A Anonima Materie Sint & Affini S P A Processo per la preparazione di refaximina k
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
US9938298B2 (en) 2014-05-12 2018-04-10 Alfa Wassermann S.P.A. Solvated crystal form of rifaximin, production, compositions and uses thereof
CN106632396B (zh) * 2017-01-06 2019-01-11 成都樵枫科技发展有限公司 γ晶型利福昔明的制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
ES2522895T3 (es) * 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
KR101674382B1 (ko) * 2008-02-25 2016-11-09 샐릭스 파마슈티컬스 리미티드 리팍시민의 형태 및 이의 용도

Also Published As

Publication number Publication date
CA2844765C (en) 2019-07-16
CA2844765A1 (en) 2012-11-22
CN103619852B (zh) 2016-08-24
US8877770B2 (en) 2014-11-04
EP2710015A1 (en) 2014-03-26
AU2012257360B2 (en) 2016-12-01
ES2586124T3 (es) 2016-10-11
KR20180032677A (ko) 2018-03-30
MX348393B (es) 2017-06-08
CN103619852A (zh) 2014-03-05
ITMI20110890A1 (it) 2012-11-20
EP2710015B1 (en) 2016-05-18
PL2710015T3 (pl) 2017-08-31
KR20140045413A (ko) 2014-04-16
RU2593750C2 (ru) 2016-08-10
US20140107144A1 (en) 2014-04-17
RU2013156344A (ru) 2015-06-27
BR112013029706A2 (pt) 2021-07-27
WO2012156951A1 (en) 2012-11-22
BR112013029804A2 (pt) 2016-09-06
PT2710015T (pt) 2016-08-25
MX2013013465A (es) 2014-05-27

Similar Documents

Publication Publication Date Title
IL246265B (en) A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds
IL221299A (en) A process for the preparation of Rifaximine pallimorphic configuration
ZA201206095B (en) Process for the preparation of isoxazoline derivatives
ZA201305972B (en) Method for the preparation of biphephos
PL2531286T3 (pl) Sposób syntezy metanolu
PT2710015T (pt) Polimorfo de rifaximina e processo para a sua preparação
HK1199649A1 (en) Process for the preparation of polyamides
ZA201305582B (en) Process for the preparation of 4-amino-5-fluoro-3-halo-6-(sunstituted)picolinates
ZA201204365B (en) Darunavir polymorph and process for preparation thereof
SG11201400939YA (en) Process for the preparation of methoxymelonal
GB2560284B (en) Process for the 3-O-demethylation of morphinan compounds
HK1194733A1 (zh) 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體
ZA201403736B (en) Process for the preparation of sterol derivatives
ZA201207397B (en) Process for the preparation of dexlansoprazole
ZA201309713B (en) Process for the preparation of paliperidone
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
GB201119690D0 (en) Process for the preparation of compounds
SG11201400090UA (en) Process for the preparation of olefins
PT2603319E (pt) Processo para a preparação de uretanos
PL393916A1 (pl) Sposób wytwarzania związków karbapenamowych
PT2390246T (pt) Processo para a preparação de aminaftona
PL2702045T3 (pl) Nowy sposób sporządzania Etrawiryny
ZA201309732B (en) Process for the preparation of dexlansoprazole
PT2598504E (pt) Novo processo de fabrico de dimiracetam